ホームページ GPCR & G Protein GLP-1 Receptor

GLP-1 Receptor

GLP-1 Receptor製品

  • All (4)
  • GLP-1 Receptor作動薬(2)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S8256 Liraglutide Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.
Cell Rep Med, 2025, 6(6):102156
Cancers (Basel), 2025, 17(4)598
J Immunother Cancer, 2024, 12(3)e008431
S9851 Danuglipron (PF-06882961) Danuglipron (PF-06882961), a non-peptide agonist, activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33ECD.
S8256 Liraglutide Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.
Cell Rep Med, 2025, 6(6):102156
Cancers (Basel), 2025, 17(4)598
J Immunother Cancer, 2024, 12(3)e008431
S9851 Danuglipron (PF-06882961) Danuglipron (PF-06882961), a non-peptide agonist, activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33ECD.
S8256 Liraglutide Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.
Cell Rep Med, 2025, 6(6):102156
Cancers (Basel), 2025, 17(4)598
J Immunother Cancer, 2024, 12(3)e008431
S9851 Danuglipron (PF-06882961) Danuglipron (PF-06882961), a non-peptide agonist, activates the canonical G protein signaling activity only in the Glucagon-like peptide-1 (GLP-1) receptor with Trp33ECD.
united states